fluoxetine has been researched along with Hypertrophic Pyloric Stenosis in 2 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Among the significant associations found, an association between maternal use of fluoxetine and infantile hypertrophic pyloric stenosis (IHPS) was of particular interest." | 3.76 | Fluoxetine and infantile hypertrophic pylorus stenosis: a signal from a birth defects-drug exposure surveillance study. ( Bakker, MK; de Jong-Van den Berg, LT; De Walle, HE; Wilffert, B, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghosh, R | 1 |
| Shenoy, S | 1 |
| Lewis, LES | 1 |
| Kumar, V | 1 |
| Bakker, MK | 1 |
| De Walle, HE | 1 |
| Wilffert, B | 1 |
| de Jong-Van den Berg, LT | 1 |
2 other studies available for fluoxetine and Hypertrophic Pyloric Stenosis
| Article | Year |
|---|---|
Infantile hypertrophic pyloric stenosis following maternal exposure to Fluoxetine: A case report.
Topics: Female; Fluoxetine; Humans; Infant; Maternal Exposure; Pyloric Stenosis, Hypertrophic; Risk Factors | 2021 |
Fluoxetine and infantile hypertrophic pylorus stenosis: a signal from a birth defects-drug exposure surveillance study.
Topics: Abnormalities, Drug-Induced; Confidence Intervals; Female; Fluoxetine; Humans; Infant; Infant, Newbo | 2010 |